Read the full story here Web Link posted Tuesday, June 30, 2020, 3:55 PM
Town Square
The cost of COVID-19 drug remdesivir: $2,340 to $3,120 per patient
Original post made on Jul 1, 2020
Read the full story here Web Link posted Tuesday, June 30, 2020, 3:55 PM
Comments (1)
Posted by Steve Taffee
a resident of Menlo Park: The Willows
on Jul 1, 2020 at 5:18 pm
a resident of Menlo Park: The Willows
on Jul 1, 2020 at 5:18 pm
In situations like this I believe that the Federal Government has a role in bringing the price down even further by allowing generics to enter the market for this particular use of remdesivir in treating patients with COVID 19.
Created in 2009 I suspect (but may be off-base here) that Gillead has recouped much of its original investment. Even if this is not the case, it is in the public interest to distribute as much of it as cheaply as possible around the world. The U.S. ha already purchased 500,000 doses representing nearly 100% of Gillead's manufacturing capacity through September. What's the rest of the world supposed to do?
Don't miss out
on the discussion!
Sign up to be notified of new comments on this topic.
Post a comment
Stay informed.
Get the day's top headlines from Almanac Online sent to your inbox in the Express newsletter.
